Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 178

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 178
---
 addition, if the U.S. Internal Revenue Service, or the IRS, determines that NLS is a PFIC for a year with respect to which NLS has determined that NLS was not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark -to-marketelection. U.S. taxpayers that have held the NLS Common Shares during a period when NLS was a PFIC will be subject to the foregoing rules, even if NLS cease to be a PFIC in subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark -to-marketelection. A U.S. taxpayer can make a QEF election by completing the relevant portions of and filing IRS Form 8621 in accordance with the instructions thereto. NLS intends to make available to U.S. taxpayers upon request the information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which NLS or any of its subsidiaries are a PFIC. U.S. taxpayers that hold the NLS Common Shares are strongly urged to consult their tax advisors about the PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them of making a QEF or mark -to-marketelection with respect to the NLS Common Shares in the event that NLS is a PFIC. NLS has not paid, and does not intend to pay, dividends on its NLS Common Shares and, therefore, unless its traded securities appreciate in value, its investors may not benefit from holding its NLS Common Shares. NLS has never declared or paid cash dividends on its NLS Common Shares. NLS does not anticipate paying any cash dividends on its NLS Common Shares in the foreseeable future. Moreover, Swiss Law imposes certain restrictions on its ability to declare and pay dividends. See “Comparison of Shareholders’ Rights and Corporate Governance — Summary of Material Differences Between the Rights of Kadimastem Shareholders and NL Shareholders — Rights of NLS Pharmaceutics shareholders — Dividends”for additional information. 54 If NLS cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of Nasdaq, NLS’s securities may not be listed or may be delisted, which could negatively impact the price of its securities and your ability to sell them. Under the Merger Agreement, each party’s obligation to complete the Merger is subject to the satisfaction or waiver of various